Blade Therapeutics is a discovery stage drug development company. Their mission is to create antifibrotic treatment strategies that address a wide variety of congenital and acquired diseases of fibrosis. Their leadership team has extensive experience at developing drugs that treat fibrotic disorders. They are also partnering with internationalexperts in order to identify and in-license cutting-edge technologies to build a robust pipeline of antifibrotic compounds.

Blade Therapeutics

Similar companies